Manufacturer record
Biozenta Lifesciences Pvt. Ltd: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
1 batch manufactured by Biozenta Lifesciences Pvt. Ltd was declared Not of Standard Quality in November 2023. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: OL23085, DOXORUBICIN HYDROCHLORIDE FOR INJECTION BP 10 MG (DOXOTERO - 10) (exp May 2025). CDL Kolkata (CDSCO lab) found it not of standard quality: Related Substances & water. Listed in the November 2023 alert.
Records by type
1 record linked to Biozenta Lifesciences Pvt. Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| DOXORUBICIN HYDROCHLORIDE FOR INJECTION BP 10 MG (DOXOTERO - 10) | Batch OL23085Mfg Jun 2023 · Exp May 2025 | Related Substances & waterRelated substances | CDL KolkataCDSCO lab | Nov 2023 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.